Press release
Global Messenger RNA (mRNA)-Based Vaccines and Therapeutics Market Size Expected to Witness Significant Growth by 2034, estimates DelveInsight
DelveInsight's "Global Messenger RNA (mRNA)-based Vaccines and Therapeutics Market Insights, Epidemiology, and Market Forecast-2034" report delivers an in-depth understanding of mRNA-based vaccines and therapeutics, historical and forecasted epidemiology, as well as market trends in the United States, EU4 (Germany, France, Italy, and Spain), the United Kingdom, and Japan.
Discover Key Insights into the mRNA Vaccines and Therapeutics Market with DelveInsight's In-Depth Report @ Global Messenger RNA (mRNA)-based Vaccines and Therapeutics Market Size [https://www.delveinsight.com/sample-request/global-messenger-rna-mrna-based-vaccines-and-therapeutics-market?utm_source=abnewswire&utm_medium=pr&utm_campaign=kkpr]
Key Takeaways from the mRNA Vaccines and Therapeutics Market Report
*
In January 2026 - Arcturus Therapeutics Holdings Inc. continued advancing its cystic fibrosis pipeline, building on the successful approval of the Clinical Trial Application (CTA) for ARCT-032, its inhaled investigational mRNA therapy. The candidate has progressed through early-stage clinical development and remains a key component of the company's strategy to address unmet needs in cystic fibrosis and other rare respiratory diseases.
*
In January 2026 - CSL Limited, through its subsidiary CSL Seqirus, continued to leverage its global collaboration and licensing partnership with Arcturus Therapeutics Holdings Inc.. The agreement provides access to Arcturus' self-amplifying mRNA (sa-mRNA) vaccine platform, supporting the development of next-generation vaccine candidates and strengthening CSL Seqirus' capabilities in innovative vaccine technologies.
*
The leading mRNA Vaccines and Therapeutics companies include Pfizer Inc., BioNTech SE, Moderna, Inc., Gennova Biopharmaceuticals Limited, GSK plc., Daiichi Sankyo, Arcturus, Boehringer Ingelheim International GmbH, Ethris GmbH, CureVac SE, AIM Vaccine Corporation, Argos Therapeutics Inc., Sanofi, Kernal Biologics Inc., and others.
*
Technological advancements in mRNA platforms - including improved delivery systems and enhanced stability - are primary drivers of market expansion.
*
Rising demand for rapid vaccine development (e.g., COVID-19, influenza) and personalized cancer immunotherapies is fueling market growth globally.
*
The Global mRNA Vaccines and Therapeutics market in the 7MM is expected to witness major change during the study period 2020-2034.
*
Supportive government initiatives, grants, and public-private partnerships are enhancing research, development, and commercialization of mRNA-based products.
*
Strategic collaborations between biotech companies, pharmaceutical firms, and research institutions are accelerating product development and market penetration.
*
Streamlined regulatory approvals and increasing market access are encouraging broader adoption and global market growth.
Stay ahead in the mRNA Vaccines and Therapeutics Market with DelveInsight's Strategic Report @ Global Messenger RNA (mRNA)-based Vaccines and Therapeutics Market Outlook [https://www.delveinsight.com/sample-request/global-messenger-rna-mrna-based-vaccines-and-therapeutics-market?utm_source=abnewswire&utm_medium=pr&utm_campaign=kkpr]
mRNA Vaccines and Therapeutics Epidemiology Segmentation in the 7MM
*
Total mRNA Vaccines and Therapeutics Market Size
*
Market Size by Therapies
*
Market Size by Class
*
mRNA Treatment Market
*
mRNA Pipeline Analysis
mRNA Vaccines and Therapeutics Pipeline Analysis
Pfizer Inc. / BioNTech SE - mRNA Vaccine Platform: Pioneered mRNA vaccine technology with the COVID-19 vaccine and now expanding into influenza, oncology, and other infectious diseases using advanced lipid nanoparticle (LNP) delivery systems.
Moderna, Inc. - mRNA-1283 / mRNA Therapeutics: Next-generation mRNA platform targeting respiratory diseases, cancer immunotherapies, and rare diseases, with a focus on improved lipid nanoparticle delivery and self-amplifying mRNA technologies.
GSK plc. - mRNA Vaccine Programs: Developing mRNA-based vaccines and therapeutics across infectious disease and oncology indications through strategic collaborations and in-house capabilities.
CureVac SE - mRNA Technology Platform: Proprietary mRNA technology platform with a pipeline spanning prophylactic vaccines, cancer therapies, and molecular therapy for rare diseases.
Daiichi Sankyo - mRNA Oncology Programs: Oncology-focused mRNA therapeutics pipeline leveraging mRNA for next-generation cancer treatment in combination with antibody-drug conjugate approaches.
Arcturus Therapeutics - LUNAR mRNA Platform: Proprietary lipid-mediated delivery platform (LUNAR) for mRNA medicines, targeting liver diseases, respiratory conditions, and vaccines.
Sanofi - mRNA Vaccines & Therapeutics: Investing in mRNA vaccine and therapeutic platforms through partnerships and acquisitions to build out a next-generation immunology pipeline.
Boehringer Ingelheim - mRNA Therapeutics: Developing mRNA-based therapeutic applications with focus on respiratory and metabolic diseases.
mRNA Vaccines and Therapeutics Market Insights
The current mRNA treatment landscape includes prophylactic vaccines (infectious disease), therapeutic cancer vaccines, personalized cancer immunotherapies, and mRNA-based protein replacement therapies for rare and metabolic diseases.
mRNA technology has emerged as a transformative pillar of modern medicine - particularly following the success of COVID-19 vaccines - demonstrating the platform's capacity for rapid development, scalability, and broad applicability across disease areas.
The competitive landscape is highly dynamic and innovation-driven, with leading players advancing lipid nanoparticle delivery systems, self-amplifying mRNA, circular mRNA, and next-generation personalized cancer vaccines.
Strategic collaborations, licensing agreements, and mergers and acquisitions are common as companies seek to strengthen pipelines and access novel delivery platforms. Public-private partnerships, government funding, and regulatory fast-track designations are further accelerating market development.
The expected introduction of emerging therapies with improved efficacy, greater disease awareness, and higher diagnosis rates are likely to boost market growth across the 7MM throughout the forecast period.
Get In-Depth Knowledge on mRNA Vaccines and Therapeutics Market Trends and Forecasts with DelveInsight @https://www.delveinsight.com/sample-request/global-messenger-rna-mrna-based-vaccines-and-therapeutics-market?utm_source=abnewswire&utm_medium=pr&utm_campaign=kkpr
mRNA Vaccines and Therapeutics Market Outlook
mRNA vaccines and therapeutics represent a paradigm shift in medicine - harnessing the body's own cellular machinery to produce therapeutic proteins, antigens, or immune modulators. Unlike conventional biologics, mRNA does not alter the genome and can be designed, synthesized, and scaled rapidly.
Well-established mRNA delivery platforms include lipid nanoparticles (LNPs), polymeric nanoparticles, and emerging self-amplifying mRNA technologies. The pipeline is highly robust with potential therapies under investigation across oncology, infectious disease, rare genetic conditions, and autoimmune disorders. The treatment space is expected to experience a significant market impact during the forecast period. Market growth may be moderated by therapy failures or discontinuations, manufacturing scale-up challenges, cold-chain distribution requirements, high pricing, and market access and reimbursement barriers.
Scope of the mRNA Vaccines and Therapeutics Market Report
*
Coverage: 7MM
*
Study Period: 2020-2034
*
Forecast Period: 2023-2034
*
Key Companies: Pfizer Inc., BioNTech SE, Moderna, Inc., Gennova Biopharmaceuticals Limited, GSK plc., Daiichi Sankyo, Arcturus, Boehringer Ingelheim International GmbH, CureVac SE, Sanofi, Kernal Biologics Inc., and others
*
Key Therapies: mRNA COVID-19 vaccines, mRNA influenza vaccines, personalized cancer mRNA vaccines, mRNA protein replacement therapies, and others
*
Market Access & Reimbursements, Unmet Needs and Perspectives
*
SWOT Analysis and KOL Views
Unlock Strategic Insights with DelveInsight's Comprehensive mRNA Market Report @ Global Messenger RNA (mRNA)-based Vaccines and Therapeutics Market Drivers and Barriers [https://www.delveinsight.com/sample-request/global-messenger-rna-mrna-based-vaccines-and-therapeutics-market?utm_source=abnewswire&utm_medium=pr&utm_campaign=kkpr]
Table of Contents
1. Key Insights
2. Executive Summary
3. Competitive Intelligence Analysis
4. Market Overview
5. Disease Background and Overview
6. Patient Journey
7. Epidemiology and Patient Population
8. Treatment Landscape
9. Unmet Needs
10. Key Clinical Endpoints
11. Marketed Products
12. Emerging Therapies
13. Seven Major Markets (7MM) Analysis
14. Market Outlook (2020-2034)
15. Access and Reimbursement Overview
16. KOL Perspectives
17. Market Drivers
18. Market Barriers
19. Research Methodology
20. Appendix
21. About DelveInsight
About Us
DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Kanishk Kumar
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=global-messenger-rna-mrnabased-vaccines-and-therapeutics-market-size-expected-to-witness-significant-growth-by-2034-estimates-delveinsight]
Phone: +14699457679
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/
Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Messenger RNA (mRNA)-Based Vaccines and Therapeutics Market Size Expected to Witness Significant Growth by 2034, estimates DelveInsight here
News-ID: 4545479 • Views: …
More Releases from ABNewswire
Tundrr Carbon-Based Soil Conditioner for Global Buyers: Specification-Led Sourci …
Tundrr Carbon-Based Soil Conditioner provides global buyers with a specification-led soil-improvement sourcing option from China. Formulated with greater than or equal to 35% organic matter, greater than or equal to 25% biochar, plus defined calcium, silicon, and magnesium content, it is designed for soil-structure and acidic-soil management programs. Tundrr supports quality control and export coordination for agricultural buyers.
As growers, agricultural distributors, private-label programs, and soil-management projects place greater emphasis on…
ROAM Roof & Solar Launches Radiant Barrier Service as Central Texas Homeowners S …
As ERCOT forecasts record power demand across Texas this summer, Belton-based ROAM Roof & Solar has launched a radiant barrier program backed by U.S. Department of Energy testing - aimed at helping homeowners reduce attic heat and ease the strain on rising electric bills.
BELTON, Texas - July 30, 2026 - ROAM Roof & Solar, a veteran-owned roofing, siding, gutters, solar, and waterproofing company, today announced the launch of its radiant…
Sunbird Carpet Cleaning of Columbia Says One Red Wine Spill Still Stands Out Aft …
The call came on a Tuesday morning from a homeowner in Columbia's Hickory Ridge neighborhood. Friends had gathered over the weekend, someone tipped over a glass of Cabernet, and red wine soaked into a light-colored living room carpet. The family reached for paper towels, club soda, and a grocery-store stain remover. Three days later, the stain had grown darker, the carpet felt stiff, and the spill had spread well beyond…
Baltimore Carpet & Upholstery Finds a Home Office Frozen in Time Beneath One Des …
The desk hadn't moved in nearly five years. When a Roland Park homeowner finally rolled it aside before a scheduled carpet cleaning, technicians from Baltimore Carpet & Upholstery uncovered something few people expect to see: a detailed record of thousands of workdays preserved in the carpet since 2020.
A software engineer living in Baltimore's Roland Park neighborhood scheduled a carpet cleaning after deciding to reclaim a spare bedroom that had served…
More Releases for RNA
Small Interfering RNA (siRNA) Therapeutics Market Growth (2026-2033) | RNA Drugs …
DataM Intelligence has released a new research report titled "Small Interfering RNA (siRNA) Therapeutics Market Size 2026" The report delivers in-depth insights into key market dynamics, including regional growth trends, market segmentation, CAGR projections, and the revenue performance of leading industry players. It also highlights major growth drivers shaping the market landscape. Designed to provide a clear and comprehensive perspective, the report offers a detailed view of the current market…
CD Formulation Launches Custom Circular RNA Synthesis Service to Accelerate RNA …
CD Formulation introduces a customizable circRNA synthesis service, delivering high-quality, stable circRNAs for therapeutics, vaccines, and gene research, supported by advanced design and QC processes.
CD Formulation, a leading provider of advanced small nucleic acid synthesis [https://www.formulationbio.com/nucleic-acid/custom-small-nucleic-acid-synthesis.html] solutions, is proud to announce the launch of its fully customizable circular RNA (circRNA) synthesis service. This new service addresses the growing need for stable, non-immunogenic RNA molecules for therapeutic development, vaccine research, and…
Self-Amplifying RNA Synthesis Market Gains Traction as Biotech Firms Embrace Sca …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the " Self-Amplifying RNA Synthesis Market- (By Product & Service (Products (Enzymes & Reagents, Premade saRNA, Others), Custom Synthesis Services), By Application (Therapeutics Development (Oncology, Infectious Diseases, Others), Biomedical Research), By End-User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Others)), Trends, Industry Competition Analysis, Revenue and Forecast To 2034."
According to the latest research by InsightAce Analytic,…
RNA Extraction and RNA Purification Market: Growth, Trends & Competitive Landsca …
The global RNA Extraction and RNA Purification Market is expected to grow at 6.3% CAGR from 2025 to 2032.
This Market Report is the result of extensive research and analysis conducted by our team of experienced market researchers through -
• 70% efforts of Primary Research
• 15% efforts of Secondary Research
• 15% efforts from the subscription to Paid database providing industry overview, macro and micro economics factors, and financials of private limited…
RNA Targeting Small Molecules Therapeutics Market: Exponential Growth with Risin …
Estimations Predict a CAGR of 29.8% by 2029 in Global RNA Targeting Small Molecules Therapeutics Market Boosted by Precision Medicine, RNA Biomarker Identification and RNA Genetic Manipulation
What Is The Projected Market Size of The Global RNA Targeting Small Molecules Therapeutics Market And Its Growth Rate?
• The market will grow from $6.1 billion in 2024 to $7.87 billion in 2025 at a compound annual growth rate (CAGR) of 28.9%.
• Expected exponential…
Global DNARNA Extraction Kit Market by Type (Cell-free DNA (cfDNA), Sequence-spe …
"DNARNA Extraction Kit Market" is segmented by Company, Region (country), By Type, Application, stakeholders and other participants. This report provides an analysis of revenue and forecast across Type and Application segments for 2023-2032.
The market for DNARNA Extraction Kits has been thoroughly researched via primary and secondary sources to produce this research study. Along with a competitive analysis of the market, segmented by application, type, and geographical trends, it offers a…
